As of September 2024, GenMont Biotech Incorporation has a market cap of $63.95M. This makes GenMont Biotech Incorporation the world's 23895th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $63.27M | -5.06% |
2023 | $66.65M | 4.22% |
2022 | $63.95M | -2.67% |
2021 | $65.70M | 9.19% |
2020 | $60.17M | -10.44% |
2019 | $67.18M | -6.74% |
2018 | $72.04M | 16.09% |
2017 | $62.06M | -2.13% |
2016 | $63.41M | -3.09% |
2015 | $65.43M | -32.36% |
2014 | $96.73M | -14.46% |
2013 | $113.08M | -8.95% |
2012 | $124.20M | 30.56% |
2011 | $95.13M | -58.77% |
2010 | $230.72M | 24.29% |
2009 | $185.62M | 537.66% |
2008 | $29.11M | - |